Requested symbol wasn't found

U.S. Markets closed

(MDVN)


NasdaqGS . Currency in USD
Add to watchlist
People also watch:
BMRNALXNSGENREGNVRTX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is ONEOK, Inc. (OKE) Going to Burn You?
    Insider Monkey6 days ago

    Is ONEOK, Inc. (OKE) Going to Burn You?

    Is ONEOK, Inc. (NYSE:OKE) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. […]

  • Market Realist12 days ago

    The Pfizer-Medivation Deal, Completed in 3Q16

    On September 27, Pfizer completed the acquisition of Medivation. The stock transaction is valued at $81.50 per Medivation share for a total of ~$14 billion.

  • Bristol Myers Squibb Co. (BMY), Alkermes Plc (ALKS) & More: How Opus Point’s Bet on Healthcare Sector Paid Off?
    Insider Monkey23 days ago

    Bristol Myers Squibb Co. (BMY), Alkermes Plc (ALKS) & More: How Opus Point’s Bet on Healthcare Sector Paid Off?

    Opus Point Partners Management is a New York-based fund led by Michael S. Weiss and Lindsay A. Rosenwald. Opus Point’s equity portfolio is worth $178.32 million as of the end of September, up from $103.54 million at the end of June. The fund invests mainly in healthcare stocks, which amass around 73% of its equity portfolio. […]